Skin biopsies are associated with a lower risk of rehospitalization among hospitalized patients with skin and soft tissue infections: a cross-sectional study.

International Journal of DermatologyEarly View Correspondence Skin biopsies are associated with a lower risk of rehospitalization among hospitalized patients with skin and soft tissue infections: a cross-sectional study Karissa Libson BA, Karissa Libson BA The Ohio State University College of Medicine, Columbus, OH, USASearch for more papers by this authorKirsten Johnson MD, Kirsten Johnson MD orcid.org/0000-0003-2388-0621 Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorJose A. Plaza MD, Jose A. Plaza MD Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorCatherine Chung MD, Catherine Chung MD Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorKristopher Fisher MD, Kristopher Fisher MD Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorAbraham M. Korman MD, Abraham M. Korman MD Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorBenjamin H. Kaffenberger MD, MS, Corresponding Author Benjamin H. Kaffenberger MD, MS [email protected] Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this author Karissa Libson BA, Karissa Libson BA The Ohio State University College of Medicine, Columbus, OH, USASearch for more papers by this authorKirsten Johnson MD, Kirsten Johnson MD orcid.org/0000-0003-2388-0621 Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorJose A. Plaza MD, Jose A. Plaza MD Department of Pathology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorCatherine Chung MD, Catherine Chung MD Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorKristopher Fisher MD, Kristopher Fisher MD Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorAbraham M. Korman MD, Abraham M. Korman MD Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this authorBenjamin H. Kaffenberger MD, MS, Corresponding Author Benjamin H. Kaffenberger MD, MS [email protected] Department of Dermatology, The Ohio State University Wexner Medical Center, Columbus, OH, USASearch for more papers by this author First published: 04 May 2023 https://doi.org/10.1111/ijd.16705 Conflict of interest: Dr. Benjamin Kaffenberger is an investigator for BMS, Biogen, Merck, InflaRx, OnQuality Pharmaceuticals, and the Dermatology Foundation and has consulted for Biogen, Onquality, Novocure, Novartis, and Elsevier. Funding source: None. Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL No abstract is available for this article. References 1Bystritsky RJ. Cellulitis. Infect Dis Clin North Am. 2021; 35(1): 49– 60. https://doi.org/10.1016/j.idc.2020.10.002 2Zhang M, Markova A, Harp J, Dusza S, Rosenbach M, Kaffenberger BH. Dermatology-specific and all-cause 30-day and calendar-year readmissions and costs for dermatologic diseases from 2010 to 2014. J Am Acad Dermatol. 2019; 81(3): 740– 8. https://doi.org/10.1016/j.jaad.2019.05.023 3Weng QY, Raff AB, Cohen JM, Gunasekera N, Okhovat JP, Vedak P, et al. Costs and consequences associated with misdiagnosed lower extremity cellulitis. JAMA Dermatol. 2017; 153(2): 141– 6. https://doi.org/10.1001/jamadermatol.2016.3816 4Milani-Nejad N, Zhang M, Kaffenberger BH. Association of dermatology consultations with patient care outcomes in hospitalized patients with inflammatory skin diseases. JAMA Dermatol. 2017; 153(6): 523– 8. https://doi.org/10.1001/jamadermatol.2016.6130 5Boettler MA, Kaffenberger BH, Chung CG. Cellulitis: a review of current practice guidelines and differentiation from pseudocellulitis. Am J Clin Dermatol. 2022; 23(2): 153– 65. https://doi.org/10.1007/s40257-021-00659-8 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation